🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy, safety, and tolerabili...
Status
Active Not Recruiting
Location
Northwestern Memorial Hospital ( Site 0002)
Start Date
2023-07-06
Trial ID
NCT05853367
Treatments Being Tested
This is a study evaluating the safety, pharmacokinetics, and efficacy of ca...
Status
Recruiting
Location
Moffitt Cancer Center ( Site 0261)
Start Date
2021-12-17
Trial ID
NCT05067283
Treatments Being Tested
The purpose of this study is to learn what happens to calderasib levels in ...
Status
Completed
Location
Arizona Clinical Trials ( Site 0003)
Start Date
2025-11-05
Trial ID
NCT07219550
Treatments Being Tested
The goal of this study is to learn what happens to calderasib in a healthy ...
Status
Completed
Location
Celerion (Site 0001)
Start Date
2024-05-20
Trial ID
NCT06719557
Treatments Being Tested
The purpose of this study is to evaluate the effect of food, formulation, a...
Status
Completed
Location
Celerion (Site 0001)
Start Date
2023-09-20
Trial ID
NCT06619314
Treatments Being Tested
This is a phase 3, randomized, double-blind study of adjuvant calderasib pl...
Status
Recruiting
Location
Instituto Alexander Fleming ( Site 0310)
Start Date
2026-03-18
Trial ID
NCT07431827
Treatments Being Tested
This study has 2 parts. Researchers want to learn what happens to calderasi...
Status
Completed
Location
Celerion ( Site 0001)
Start Date
2025-05-13
Trial ID
NCT06942741
Treatments Being Tested
Researchers want to learn if MK-1084, the study medicine, can treat advance...
Status
Recruiting
Location
Clermont Oncology Center ( Site 0041)
Start Date
2026-04-30
Trial ID
NCT07286149
Treatments Being Tested
Researchers want to learn about calderasib when given with rosuvastatin and...
Status
Completed
Location
Celerion ( Site 0001)
Start Date
2025-11-19
Trial ID
NCT07222098
Treatments Being Tested
Researchers want to learn if using a study medicine called MK-1084 can help...
Status
Recruiting
Location
Clermont Oncology Center ( Site 0041)
Start Date
2025-12-19
Trial ID
NCT07252739
Treatments Being Tested